Get started
Author

Mehmet Eren Kalender

Observed name: M E Kalender
ORCID: 0000-0002-2702-0170
Observed ORCID: 0000-0002-2702-0170
OpenAlex ID: A5055268575
HALP score and GNRI: Simple and easily accessible indexes for predicting prognosis in advanced stage NSCLC patients. The İzmir oncology group (IZOG) study
2022 · Zeynep Gülsüm Güç, Ahmet Alacacıoğlu, et al. · Frontiers in Nutrition · 70
PDF
A Rare Case of Systemic Lupus Erythematosus with Chylous Ascites and Chylothorax
2013 · Dilek Ersil Soysal, Sezin Hizar Turan, et al. · Case Reports in Rheumatology · 21
PDF
Being a Cancer Patient during the Time of COVID-19: Impact of the Pandemic on the Anxiety and the Sleeping Quality of Oncology Patients
2021 · Zeynep Gülsüm Güç, Ahmet Alacacıoğlu, et al. · Chemotherapy · 8
Therapeutic Potential of Pioglitazone-Augmented Indocyanine Green-Driven Photodynamic Therapy in Papillary Thyroid Cancer: An In Vitro Study
2026 · Derya Sema Yaman Kalender, Mehmet Eren Kalender, et al. · Photobiomodulation Photomedicine and Laser Surgery
Neurotrophic–Inflammatory Imbalance and Cognitive Decline After Adjuvant Chemotherapy in Colon Cancer: A Prospective Cohort Study
2026 · Zeynep Gülsüm Güç, Leyla Demir, et al. · Psycho-Oncology
The effects of pioglitazone on indocyanine green-mediated photodynamic therapy against papillary thyroid cancer
2025 · Derya Sema Yaman Kalender, Mehmet Eren Kalender, et al. · Translational Biophotonics: Diagnostics and Therapeutics
Relevancy of Serum SuPAR, PAI-1, MMP-9 Level, and Prognosis of Metastatic Colorectal Cancer During Diagnosis
2022 · Mehmet Eren Kalender, Leyla Demir, et al. · Eurasian Journal of Medical Advances
PDF
Works count: 9
Citation count: 101
H-index: 3
I10-index: 2
Year
Topic
Type